iShares Biotechnology ETF (NASDAQ:IBB) Shares Sold by Kingswood Wealth Advisors LLC

Kingswood Wealth Advisors LLC decreased its position in iShares Biotechnology ETF (NASDAQ:IBB) by 20.7% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,197 shares of the financial services provider’s stock after selling 574 shares during the quarter. Kingswood Wealth Advisors LLC’s holdings in iShares Biotechnology ETF were worth $302,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of IBB. Crewe Advisors LLC raised its position in iShares Biotechnology ETF by 42.9% during the fourth quarter. Crewe Advisors LLC now owns 260 shares of the financial services provider’s stock valued at $35,000 after buying an additional 78 shares during the period. Apexium Financial LP grew its stake in iShares Biotechnology ETF by 3.8% in the fourth quarter. Apexium Financial LP now owns 2,223 shares of the financial services provider’s stock valued at $302,000 after purchasing an additional 82 shares in the last quarter. HB Wealth Management LLC grew its stake in iShares Biotechnology ETF by 5.9% in the fourth quarter. HB Wealth Management LLC now owns 1,892 shares of the financial services provider’s stock valued at $257,000 after purchasing an additional 105 shares in the last quarter. Peterson Wealth Management grew its stake in iShares Biotechnology ETF by 2.9% in the third quarter. Peterson Wealth Management now owns 3,743 shares of the financial services provider’s stock valued at $458,000 after purchasing an additional 106 shares in the last quarter. Finally, Belpointe Asset Management LLC grew its stake in iShares Biotechnology ETF by 2.4% in the third quarter. Belpointe Asset Management LLC now owns 4,588 shares of the financial services provider’s stock valued at $561,000 after purchasing an additional 108 shares in the last quarter. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

Shares of NASDAQ IBB opened at $137.26 on Friday. The business’s 50-day moving average price is $134.42 and its two-hundred day moving average price is $134.82. iShares Biotechnology ETF has a one year low of $111.83 and a one year high of $141.16.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.